Received Mar 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y004554 | SC / LA |
Patient developed shingles on 3/20/2025. He has required prolong hospitalization and IV acyclovir. Pediatric ID consulted as well as Dermatology
unknown
PMHx significant for BPD/CLD, CRF with ventilator dependence, impaired airway clearance NEC with bowel perforation and resection, congenital hydronephrosis with UPJ obstruction s/p ureteral stent placement, adrenal insufficiency
Albuterol, pepcid, iron supplements, mirlax, simethicone
Chlorhexidine
Varicella Zoster PCR positive